The  (MSAA) is pleased to provide vital services and resources to individuals affected by MS, their families, and care ...

Multiple Sclerosis, the most common neurological disorder in young adults, with symptoms usually occurring between the ages of 20 and 40 years. The rising prevalence of multiple sclerosis (MS) is ...

Recent highlights in MS coverage focus on biomarkers, pregnancy, and neurodegeneration. Physician’s Weekly has compiled a ...

Yes, columnist Ben Hofmeister has MS, but he'd like to be remembered for something other than his disability or mobility devices.

More than 90% of RRMS patients given vidofludimus calcium in a clinical trial were free of confirmed disability worsening ...

Denali Therapeutics remains an intriguing clinical-stage biotech focused on neurodegenerative and lysosomal storage diseases.

Multiple sclerosis (MS) includes both peripheral and central nervous system (CNS) inflammation, and an anti-inflammatory ...

"Our results identify potentially disease-facilitating bacteria sampled from the ileum of multiple sclerosis affected twins," ...

Historically, optic nerve involvement has been excluded from MS diagnostic criteria, but its inclusion in the new iteration is expected to significantly accelerate time to diagnosis.

Multiple sclerosis is assumed to be a rare condition in our country, but it is probably undiagnosed and almost certainly misdiagnosed at the early stages.

Tiziana (TLSA) is showing groundbreaking advancements in Alzheimer's & MS treatments with foralumab. Key trials & market ...

'Toxic Avenger' Reboot Trailer Shows Best Look at Peter Dinklage's Toxie Governor Newsom addresses U.S. attack on Iranian ...